GO:0051262 protein tetramerization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051262 protein tetramerization is the biological process by which four noncovalently associated protein subunits assemble into a functional tetramer.
• Tetramerization is essential for the activity of many proteins, including aquaporins, p53, pyruvate kinase M2 (PKM2), and TRAP1.
• The process is often regulated by post-translational modifications, ligand binding, and cellular stress, allowing dynamic control of protein function.
• Dysregulated tetramerization contributes to cancer, cardiac ischemia/reperfusion injury, and neurodegenerative conditions.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of tetramerization in health and disease.
• EDITGENE provides comprehensive CRISPR services to study protein tetramerization, from library screening to bioinformatics analysis.
Description
Protein tetramerization (GO:0051262) is a fundamental biological process in which four protein subunits assemble into a noncovalently associated macromolecular complex. This process is critical for the function of numerous proteins across diverse cellular pathways, including membrane transport, metabolism, tumor suppression, and stress responses. Understanding the molecular mechanisms and regulation of tetramerization is essential for researchers studying protein structure-function relationships and disease mechanisms. The assembly of tetramers can be homotypic (identical subunits) or heterotypic (nonidentical subunits), and it often confers unique biochemical properties such as allosteric regulation, increased stability, or enhanced enzymatic activity. Recent studies have highlighted the importance of tetramerization in cardiac protection, cancer progression, and cellular stress adaptation, making it a focal point for therapeutic intervention. This article provides a comprehensive overview of protein tetramerization, integrating authoritative GO annotations with real PubMed literature to support research and drug discovery.
protein tetramerization At A Glance
| GO ID | GO:0051262 |
|---|---|
| GO term | protein tetramerization |
| Ontology | biological_process |
| Synonym | protein tetramer assembly, protein tetramer biosynthesis, protein tetramer biosynthetic process, protein tetramer formation |
| Major function | Assembly of four protein subunits into a noncovalently associated functional complex |
| Subunit composition | Identical (homotetramer) or nonidentical (heterotetramer) subunits |
| Cellular context | Occurs in cytoplasm, membrane, nucleus, and organelles |
| Regulation | Modulated by post-translational modifications, ligands, and stress signals |
| Disease relevance | Cancer, cardiac injury, neurodegeneration, metabolic disorders |
What Is GO:0051262?
Protein tetramerization is the formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits. This process is also known as protein tetramer assembly, biosynthesis, or formation. It is a biological process that enables proteins to achieve functional quaternary structures essential for their roles in cellular physiology.
Why Is protein tetramerization Important in Cell Biology?
Protein tetramerization is crucial because it governs the activity, stability, and interactions of many key proteins. For example, aquaporin tetramers are essential for water transport and membrane integrity, while p53 tetramerization is required for its tumor suppressor function. PKM2 tetramerization promotes cardiac glucose metabolism and protects against ischemia/reperfusion injury, and TRAP1 tetramerization enhances antioxidant and pro-neoplastic activities. Disruption of tetramerization can lead to loss of function, aggregation, or pathological signaling, making it a prime target for therapeutic intervention and a key area of biomedical research.
• Tetramerization is required for the functional activity of many enzymes, channels, and transcription factors.
• It enables allosteric regulation and cooperativity in metabolic enzymes such as PKM2.
• Dysregulated tetramerization is implicated in cancer, where it can promote pro-neoplastic activities.
• Cardiac protection against ischemia/reperfusion injury depends on PKM2 tetramerization.
• p53 tetramerization is critical for tumor suppression, and its disruption is linked to cancer.
• Aquaporin tetramerization influences membrane protein interactions and water transport.
• Reversible amyloids of pyruvate kinase couple metabolism to stress granule disassembly.
• Tetramerization can be targeted by small molecules to modulate protein function.
• CRISPR models allow precise dissection of tetramerization domains and their roles.
• Understanding tetramerization aids in designing biologics and small-molecule drugs.
What Happens During protein tetramerization?
Subunit Synthesis and Folding
In simple terms: First, the individual protein subunits are made and folded into their correct shapes.
Protein tetramerization begins with the synthesis of individual subunits on ribosomes, followed by folding into native conformations. Chaperones assist in proper folding, and post-translational modifications may occur. For example, aquaporin monomers fold in the endoplasmic reticulum before assembling into tetramers. Similarly, p53 monomers must fold correctly to form tetramers.
Subunit Recognition and Dimerization
In simple terms: Subunits find each other and pair up to form dimers.
Subunits recognize complementary interfaces, often mediated by hydrophobic or electrostatic interactions. Dimerization is a key intermediate step; for instance, p53 forms dimers via its tetramerization domain before tetramer assembly. In PKM2, dimerization is regulated by fructose-1,6-bisphosphate and other metabolites.
Tetramer Assembly and Stabilization
In simple terms: Two dimers come together to form a stable four-subunit complex.
Dimers associate to form tetramers, stabilized by noncovalent interactions such as hydrogen bonds, salt bridges, and hydrophobic packing. The tetramerization domain of p53 is highly conserved and its stability varies among species. TRAP1 tetramerization is mediated by disulfide bonds, which enhance its antioxidant function.
Functional Maturation and Regulation
In simple terms: The tetramer becomes fully functional and can be regulated by cellular signals.
Once assembled, tetramers may undergo conformational changes that enable activity. PKM2 tetramerization is promoted by MTX2 and enhances glucose metabolism, protecting the heart. Reversible amyloid formation of pyruvate kinase can sequester tetramers and affect stress granule disassembly. Regulation by phosphorylation, oxidation, or ligand binding fine-tunes tetramer stability and function.
Disassembly and Turnover
In simple terms: Tetramers can fall apart when no longer needed or under stress.
Tetramers are dynamic and can disassemble in response to cellular cues. For example, oxidative stress can promote TRAP1 tetramerization, while other conditions may lead to dissociation. The reversible nature of tetramerization allows rapid adaptation to metabolic and stress signals.
Key Genes Involved in GO:0051262 protein tetramerization
The following genes and proteins are key players in protein tetramerization, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AQP1 | Aquaporin water channel; forms homotetramers | Water transport, membrane protein interactions |
| PKM2 | Pyruvate kinase M2; tetramerization enhances glycolytic activity | Cardiac metabolism, ischemia/reperfusion injury |
| TP53 | Tumor suppressor p53; tetramerization required for DNA binding | Cancer, species-specific biophysical properties |
| TRAP1 | Mitochondrial chaperone; disulfide-mediated tetramerization | Antioxidant defense, pro-neoplastic activities |
| MTX2 | Metaxin-2; facilitates PKM2 tetramerization | Cardiac glucose metabolism, cardioprotection |
| H3 | Histone H3; part of histone tetramers during replication | Chromatin assembly, parental histone transfer |
| H4 | Histone H4; forms tetramers with H3 | Nucleosome assembly, epigenetic inheritance |
| Selenoprotein P | Selenoprotein; may form multimers | Selenium transport, antioxidant defense |
| Pyruvate kinase | Glycolytic enzyme; reversible amyloid formation | Stress granule disassembly, metabolism |
| Aquaporin 4 | Brain aquaporin; tetrameric assembly | Cerebral edema, water homeostasis |
| p53 mutants | Altered tetramerization domains | Cancer predisposition, dominant-negative effects |
| TRAP1 mutants | Disulfide bond disruption | Cancer cell survival, redox regulation |
| PKM2 mutants | Impaired tetramerization | Metabolic reprogramming, cardiac injury |
| Histone chaperones | Assist histone tetramer formation | DNA replication, chromatin dynamics |
| Aquaporin 2 | Kidney aquaporin; tetrameric | Water reabsorption, diabetes insipidus |
| Aquaporin 5 | Salivary/gland aquaporin; tetrameric | Secretory function, Sjögren's syndrome |
| p53 family members | p63/p73; tetramerization domains | Development, cancer |
| Selenoprotein W | Small selenoprotein; possible multimerization | Muscle function, redox |
How Is protein tetramerization Regulated?
Protein tetramerization is regulated at multiple levels. Post-translational modifications such as phosphorylation, oxidation, and disulfide bond formation can stabilize or destabilize tetramers. Ligand binding, such as fructose-1,6-bisphosphate for PKM2, promotes tetramerization. Cellular stress, including oxidative stress, can induce TRAP1 tetramerization via disulfide bonds. Additionally, the availability of binding partners like MTX2 facilitates PKM2 tetramerization. Reversible amyloid formation can sequester tetramers and regulate stress granule dynamics. These regulatory mechanisms ensure that tetramerization is dynamic and responsive to cellular needs.
protein tetramerization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer (Li-Fraumeni syndrome, sporadic tumors) | Knock-in of tetramerization-domain mutations in cell lines |
| PKM2 | Cardiac ischemia/reperfusion injury, metabolic disorders | Cardiomyocyte-specific knockout or overexpression |
| TRAP1 | Cancer (pro-neoplastic activities), oxidative stress | Point mutation of cysteine residues to prevent disulfide-mediated tetramerization |
| AQP1 | Cerebral edema, water balance disorders | Knockout in astrocytes or kidney cells |
| MTX2 | Cardiac metabolism, cardioprotection | Overexpression or knockout in cardiac cells |
Cancer
Dysregulated tetramerization is implicated in cancer. p53 tetramerization is essential for its tumor suppressor function; mutations in the tetramerization domain impair DNA binding and promote cancer. TRAP1 tetramerization via disulfide bonds enhances its antioxidant and pro-neoplastic activities, supporting cancer cell survival. Targeting tetramerization interfaces is a potential therapeutic strategy.
Cardiac Ischemia/Reperfusion Injury
PKM2 tetramerization, facilitated by MTX2, promotes cardiac glucose metabolism and protects the heart against ischemia/reperfusion injury. Enhancing tetramerization may be cardioprotective, while its disruption exacerbates injury.
Neurodegeneration and Stress Responses
Reversible amyloids of pyruvate kinase couple cell metabolism to stress granule disassembly, implicating tetramerization dynamics in neurodegenerative conditions. Aquaporin tetramers in the brain are critical for water homeostasis; their dysfunction contributes to cerebral edema.
Metabolic Disorders
Tetramerization of metabolic enzymes like PKM2 affects glucose metabolism, linking it to diabetes and metabolic syndrome. Selenoproteins, some of which may multimerize, play roles in redox balance and metabolic health.
From protein tetramerization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of tetramerization affect protein function? | CRISPR knockout of the tetramerization domain or entire gene |
| How do point mutations in the tetramerization interface alter assembly? | CRISPR point mutation (e.g., p53 tetramerization domain mutants) |
| Can a tagged tetramerization domain be used to track assembly? | Knock-in of fluorescent or affinity tags |
| Does overexpression of a partner enhance tetramerization? | Overexpression of MTX2 or other facilitators |
| What is the role of disulfide bonds in tetramer stability? | Point mutation of cysteine residues (e.g., TRAP1) |
| How does tetramerization affect stress granule dynamics? | Knockout or overexpression of pyruvate kinase mutants |
How to Study the protein tetramerization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | High-resolution structure of tetramer | Determining subunit arrangement and interfaces |
| SEC-MALS | Molecular mass and oligomeric state | Confirming tetramer formation in solution |
| Co-immunoprecipitation | Protein-protein interactions | Detecting tetramer assembly in cell lysates |
| FRET/BiFC | Real-time tetramerization in live cells | Monitoring dynamic assembly |
| CRISPR knockout | Loss-of-function of tetramerization domain | Assessing functional consequences |
| CRISPR point mutation | Specific amino acid changes | Dissecting interface residues |
| Proteomics | Interacting partners and modifications | Identifying regulators of tetramerization |
| Ribo-seq | Translational efficiency | Measuring subunit synthesis rates |
Structural and Biophysical Methods
X-ray crystallography, cryo-EM, and NMR spectroscopy can resolve tetramer structures and interfaces. Analytical ultracentrifugation and size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) determine oligomeric states. These methods are essential to validate tetramerization observed in cells.
Biochemical and Cellular Assays
Co-immunoprecipitation, crosslinking, and native PAGE can detect tetramer formation in cell lysates. Fluorescence resonance energy transfer (FRET) and bimolecular fluorescence complementation (BiFC) allow visualization of tetramerization in live cells.
Genomic and Proteomic Approaches
CRISPR screens can identify genes required for tetramerization. Proteomics, including immunoprecipitation-mass spectrometry, reveals interacting partners and post-translational modifications. RNA-seq and Ribo-seq can assess transcriptional and translational changes upon tetramerization disruption.
Imaging and Functional Studies
Super-resolution microscopy and live-cell imaging track tetramer assembly and localization. Functional assays, such as water transport for aquaporins or metabolic flux for PKM2, link tetramerization to activity.
How CRISPR Can Be Used to Study GO:0051262 protein tetramerization
Knockout
CRISPR knockout of genes encoding tetramer-forming proteins or their facilitators (e.g., MTX2) can abolish tetramerization and reveal its functional importance. Knockout cell models are valuable for studying loss-of-function phenotypes in cancer, cardiac, and metabolic research.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in tetramerization domains, such as p53 tetramerization mutants or TRAP1 cysteine mutants, to dissect the role of individual residues in assembly and function.
Knock-in
Knock-in of tags (e.g., GFP, HA) or disease-associated mutations allows tracking of tetramerization in live cells and studying pathological variants. This approach is ideal for understanding dynamic assembly and localization.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase levels of tetramer-forming proteins or facilitators, enabling studies of enhanced tetramerization and its downstream effects. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports protein tetramerization Research
Researchers studying protein tetramerization-related genes often need to determine whether a candidate gene is causally involved in assembly, function, or disease. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling rigorous investigation of tetramerization mechanisms and therapeutic targets.
Contact EDITGENE today to design your custom CRISPR model for protein tetramerization research.
Frequently Asked Questions About protein tetramerization
What is protein tetramerization?
Protein tetramerization is the biological process (GO:0051262) where four protein subunits assemble into a noncovalently associated tetramer, which is essential for the function of many proteins.
What genes are involved in protein tetramerization?
Key genes include AQP1, PKM2, TP53, TRAP1, MTX2, and histones H3/H4, among others.
Why is protein tetramerization important?
It is critical for protein activity, stability, and regulation; dysregulation is linked to cancer, cardiac injury, and neurodegeneration.
How is protein tetramerization regulated?
It is regulated by post-translational modifications, ligand binding, stress signals, and partner proteins like MTX2.
What diseases are associated with defective protein tetramerization?
Cancer, cardiac ischemia/reperfusion injury, metabolic disorders, and neurodegenerative conditions.
What methods are used to study protein tetramerization?
Cryo-EM, SEC-MALS, co-immunoprecipitation, FRET, CRISPR screens, and proteomics.
Can CRISPR be used to study protein tetramerization?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect tetramerization mechanisms.
What is the role of p53 tetramerization in cancer?
p53 tetramerization is required for its tumor suppressor function; mutations in the tetramerization domain impair DNA binding and promote cancer.
How does PKM2 tetramerization protect the heart?
PKM2 tetramerization, facilitated by MTX2, promotes cardiac glucose metabolism and protects against ischemia/reperfusion injury.
What is the significance of TRAP1 tetramerization?
Disulfide-mediated TRAP1 tetramerization enhances its antioxidant and pro-neoplastic activities, supporting cancer cell survival.
Conclusion
Protein tetramerization (GO:0051262) is a fundamental biological process that governs the assembly and function of numerous proteins. Its dysregulation is implicated in cancer, cardiac injury, and metabolic disorders, making it a key research area. Advances in CRISPR technology and structural biology continue to unravel the mechanisms and therapeutic potential of tetramerization. EDITGENE's comprehensive services empower researchers to explore this process with precision and efficiency.
References
- 1. Roche JV et al.. 2017. Aquaporin Protein-Protein Interactions.. Int J Mol Sci 18(11) PMID: 29077056
- 2. Li Y et al.. 2025. MTX2 facilitates PKM2 tetramerization to promote cardiac glucose metabolism and protects the heart against ischemia/reperfusion injury.. Theranostics 15(14):6737-6752 PMID: 40585998
- 3. Sakaguchi S et al.. 2023. Highly Similar Tetramerization Domains from the p53 Protein of Different Mammalian Species Possess Varying Biophysical, Functional and Structural Properties.. Int J Mol Sci 24(23) PMID: 38068946
- 4. Li N et al.. 2024. Parental histone transfer caught at the replication fork.. Nature 627(8005):890-897 PMID: 38448592
- 5. Zachara BA. 1992. Mammalian selenoproteins.. J Trace Elem Electrolytes Health Dis 6(3):137-51 PMID: 1483033
- 6. Cereghetti G et al.. 2021. Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly.. Nat Cell Biol 23(10):1085-1094 PMID: 34616026
- 7. Davis TN. 2004. Protein localization in proteomics.. Curr Opin Chem Biol 8(1):49-53 PMID: 15036156
- 8. Faienza F et al.. 2025. Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities.. Redox Biol 84:103677 PMID: 40424720
